| Name | Title | Contact Details |
|---|
Wellpath is the premier provider of localized, high-quality, compassionate care to vulnerable patients in challenging clinical environments. Wellpath holds patients at the center of everything we do and promotes rigorous standards of care and innovation. With nearly 15,000 clinicians and professionals in 35 states across the U.S. and Australia, Wellpath provides medical and mental healthcare services for over 240,000 patients daily in state hospitals, forensic treatment, civil commitment centers, community care centers as well as local, state and federal correctional facilities.
Success Healthcare, LLC. is an organization that manages and owns community-based acute care hospitals supported by a management team dedicated to operations and financial excellence. Our goal is to deliver consistent quality cost-efficient patient care, and programs that best serve as well as respect each individual hospital`s distinctive mission and values, its physicians, employees, and community-at-large. To do so, we provide expertise in operations, clinical, and financial resources to each of our hospitals. To deliver quality and compassionate healthcare to our patients through our employees and the physicians who practice in the communities we serve.
Pharos Life is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
Wellbeats gives people of every age, interest, body type, & ability level the same opportunity to live a healthier life.